Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 11:43 am Purchase | 2026-03-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | JANUS HENDERSON GROUP PLC JHG | 2,240,963 5.300% | 2,240,963 (New Position) | Filing History |
| 2026-05-15 08:46 am Purchase | 2026-03-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Deep Track Capital, LP | 3,600,000 8.460% | 600,000 (+20.00%) | Filing History |
| 2026-05-08 11:21 am Sale | 2026-03-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | PRUDENTIAL FINANCIAL INC PRU | 1,836,321 4.300% | -459,079 (-20.00%) | Filing History |
| 2026-05-06 4:13 pm Sale | 2026-03-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Jennison Associates LLC | 1,712,124 4.000% | -466,456 (-21.41%) | Filing History |
| 2026-03-27 1:34 pm Sale | 2026-03-13 | 13G | TARSUS PHARMACEUTICALS INC TARS | VANGUARD GROUP INC | 0 0.000% | -2,097,323 (Position Closed) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | TANG CAPITAL MANAGEMENT, LLC | 1,188,624 2.800% | -1,266,173 (-51.58%) | Filing History |
| 2025-11-14 08:23 am Purchase | 2025-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | Deep Track Capital, LP | 3,000,000 7.110% | 647,040 (+27.50%) | Filing History |
| 2025-08-14 08:08 am Purchase | 2025-06-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | RTW Investments, LP | 3,424,180 8.100% | 271,839 (+8.62%) | Filing History |
| 2025-07-28 5:00 pm Purchase | 2025-07-21 | 13G | TARSUS PHARMACEUTICALS INC TARS | Deep Track Capital, LP | 2,352,960 5.600% | 2,352,960 (New Position) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | TANG CAPITAL MANAGEMENT, LLC | 2,454,797 5.900% | 2,454,797 (New Position) | Filing History |
| 2025-05-07 11:27 am Sale | 2025-03-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Morgan Stanley MS | 1,943,453 4.700% | -252 (-0.01%) | Filing History |
| 2025-04-24 09:12 am Sale | 2025-03-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | BlackRock, Inc. BLK | 3,092,735 7.400% | -662,769 (-17.65%) | Filing History |
| 2025-02-13 12:22 pm Sale | 2024-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Cowen Financial Products LLC | 1,909,228 4.900% | -2,171 (-0.11%) | Filing History |
| 2024-11-14 4:41 pm Purchase | 2024-11-14 | 13G | TARSUS PHARMACEUTICALS INC TARS | PRUDENTIAL FINANCIAL INC PRU | 2,295,400 6.000% | 2,295,400 (New Position) | Filing History |
| 2024-11-14 4:35 pm Purchase | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | Paradigm BioCapital Advisors LP | 2,440,445 6.400% | 512,939 (+26.61%) | Filing History |
| 2024-11-14 3:05 pm Sale | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | Cormorant Asset Management, LP | 500,000 1.310% | -1,721,422 (-77.49%) | Filing History |
| 2024-11-12 6:02 pm Unchanged | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | VANGUARD GROUP INC | 2,097,323 5.510% | 0 (Unchanged) | Filing History |
| 2024-11-12 09:12 am Purchase | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | Jennison Associates LLC | 2,178,580 5.700% | 2,178,580 (New Position) | Filing History |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | BlackRock, Inc. BLK | 3,755,504 9.900% | 0 (Unchanged) | Filing History |
| 2024-11-06 10:26 am Purchase | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | Frazier Life Sciences IX, L.P. | 1,587,527 4.200% | 170,370 (+12.02%) | Filing History |